Literature DB >> 10477582

Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.

Y Tada1, K Nagasawa, A Ho, F Morito, S Koarada, O Ushiyama, N Suzuki, A Ohta, T W Mak.   

Abstract

MRL/Mpj-lpr/lpr (MRL/lpr) mice develop autoimmune disorders, including lymphoproliferation, glomerulonephritis, autoantibody production, and hypergammaglobulinemia. To investigate the role of the costimulatory molecule CD28 in the development of these disorders, MRL/lpr mice lacking CD28 were generated by gene targeting. Compared with CD28+/+ MRL/lpr mice, CD28-/- MRL/lpr mice showed decreased lymphadenopathy but increased splenomegaly associated with the expansion of abnormal B220+ TCRalphabeta+ T cells. Although levels of IgM Abs were unchanged in CD28-/- MRL/lpr mice, the production of anti-DNA IgG Abs and IgG rheumatoid factors were suppressed. IgG deposition in the glomeruli was markedly decreased, and the development of glomerulonephritis was significantly retarded. Furthermore, renal vasculitis and arthritis were absent in CD28-/- MRL/lpr mice. These results indicate that, although CD28 is not required for the generation of the abnormal T cell population in MRL/lpr mice, it does play an important role in the development of autoimmune disease in these animals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477582

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Costimulatory blockade: A novel approach to the treatment of glomerular disease?

Authors:  Pasquale Esposito; Teresa Rampino; Antonio Dal Canton
Journal:  World J Methodol       Date:  2015-06-26

Review 2.  Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice.

Authors:  Christopher M Reilly; Gary S Gilkeson
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 3.  A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity.

Authors:  Prabhakaran Kumar; Palash Bhattacharya; Bellur S Prabhakar
Journal:  J Autoimmun       Date:  2018-08-31       Impact factor: 7.094

4.  Expression of inducible co-stimulator on peripheral blood T lymphocytes in patients with lupus nephritis.

Authors:  Wen-Xian Li; Hai-Feng Pan; Guo-Ping Chen; Jin-Hui Tao; Xiang-Pei Li; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2011-04-11       Impact factor: 2.631

Review 5.  Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.

Authors:  Qianxia Zhang; Dario A A Vignali
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

6.  Age associated alterations in costimulatory and adhesion molecule expression in lupus-prone mice are attenuated by food restriction with n-6 and n-3 fatty acids.

Authors:  Alagarraju Muthukumar; Dongxu Sun; Khaliquz Zaman; J L Barnes; David Haile; Gabriel Fernandes
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

7.  Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation.

Authors:  Guo-Min Deng; George C Tsokos
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

8.  Spontaneous development of a pancreatic exocrine disease in CD28-deficient NOD mice.

Authors:  Craig Meagher; Qizhi Tang; Brian T Fife; Helene Bour-Jordan; Jenny Wu; Cecile Pardoux; Mingying Bi; Kristin Melli; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

9.  Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis.

Authors:  Zhenyue Hao; Gordon S Duncan; Jane Seagal; Yu-Wen Su; Claire Hong; Jillian Haight; Nien-Jung Chen; Andrew Elia; Andrew Wakeham; Wanda Y Li; Jennifer Liepa; Geoffrey A Wood; Stefano Casola; Klaus Rajewsky; Tak W Mak
Journal:  Immunity       Date:  2008-10-02       Impact factor: 31.745

Review 10.  Requirements for innate immune pathways in environmentally induced autoimmunity.

Authors:  Kenneth Michael Pollard; Dwight H Kono
Journal:  BMC Med       Date:  2013-04-04       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.